Rebecca Traub, MD
Neurology · Chapel Hill, NCNPI 1790943777
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,670 of the $36,438 with a category attached, or 70.4%. 6 manufacturers reported payments, led by Argenx US, Inc. at 39.6% of the total.
Across 67 payments — averaging $543.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Argenx US, Inc.$14K
- Alnylam Pharmaceuticals Inc.$9K
- CSL Behring$5K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- Sanofi$3K
- UCB, Inc.$134
Across 89 payments — averaging $5410.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$187K
- Argenx US, Inc.$125K
- AstraZeneca$84K
- Takeda Pharmaceuticals U.S.A., Inc.$44K
- Ionis Pharmaceuticals, Inc.$25K
- Vertex$16K
What the payments were for
- Consulting fees$25,67070%
- Speaking & faculty fees$4,29012%
- Travel & lodging$4,42012%
- Food & beverage$2,0586%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Argenx US, Inc. | 26 | $14,420 |
| Alnylam Pharmaceuticals Inc. | 24 | $9,022 |
| CSL Behring | 12 | $5,074 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $4,305 |
| Sanofi | 3 | $3,483 |
| UCB, Inc. | 1 | $134 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONPATTRO$7,304
- VYVGART$4,983
- Hizentra$4,789
- VYVGART HYTRULO$3,000
How this compares
$36,438 in reported general payments places this provider in the 85th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 16 | $305,224 |
| SkyclarysOmaveloxolone | 12 | $259,651 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $226,384 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 11 | $134,200 |
| Pregabalin ErPregabalin | 18 | $12,162 |
| Pyridostigmine Bromide | 55 | $6,927 |
| Mycophenolate Mofetil | 58 | $6,844 |
| Gabapentin | 124 | $3,060 |
| Pregabalin | 97 | $2,517 |
| Duloxetine Hcl | 36 | $795 |
| Levetiracetam | 11 | $767 |
| Prednisone | 31 | $520 |
| Lamotrigine | 17 | $296 |
| Cyclobenzaprine Hcl | 17 | $99 |
| Tramadol Hcl | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $5,074 | $226,38413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 566 neurology providers in North Carolina.
Other neurology in Chapel Hill
- James HowardChapel Hill$294K
- O'Neill D'cruzChapel Hill$57K
- Jill ConwayCharlotte$1M
- Matthew CarraroCharlotte$695K
- Richard SaterGreensboro$682K
- Sara SaccoMatthews$651K
- Megan DonnellyCharlotte$601K
- Kevin KahnDurham$587K
- Sanjay IyerCharlotte$581K
- Mark SkeenDurham$562K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.